These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 34914317)
21. [Focusing on MRI-suspected lesions in targeted transrectal prostate biopsy guided by MRI-TRUS fusion imaging for the diagnosis of prostate cancer]. Qu HW; Liu H; Cui ZL; Jin XB; Zhao Y; Wang MW; Song W; Zhang XJ Zhonghua Nan Ke Xue; 2016 Sep; 22(9):782-786. PubMed ID: 29071873 [TBL] [Abstract][Full Text] [Related]
22. Early experience with multiparametric magnetic resonance imaging-targeted biopsies under visual transrectal ultrasound guidance in patients suspicious for prostate cancer undergoing repeated biopsy. Boesen L; Noergaard N; Chabanova E; Logager V; Balslev I; Mikines K; Thomsen HS Scand J Urol; 2015 Feb; 49(1):25-34. PubMed ID: 24922550 [TBL] [Abstract][Full Text] [Related]
23. Surface-projection-based transperineal cognitive fusion targeted biopsy of the prostate: an original technique with a good cancer detection rate. Wang L; Wang X; Zhao W; Zhao Z; Li Z; Fei S; Zhu H; Ji X; Yang B; Li N; Na Y BMC Urol; 2019 Nov; 19(1):107. PubMed ID: 31684917 [TBL] [Abstract][Full Text] [Related]
24. Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy. Vėželis A; Platkevičius G; Kinčius M; Gumbys L; Naruševičiūtė I; Briedienė R; Petroška D; Ulys A; Jankevičius F Medicina (Kaunas); 2021 Jan; 57(1):. PubMed ID: 33435132 [No Abstract] [Full Text] [Related]
25. A cohort of transperineal electromagnetically tracked magnetic resonance imaging/ultrasonography fusion-guided biopsy: assessing the impact of inter-reader variability on cancer detection. Wajswol E; Winoker JS; Anastos H; Falagario U; Okhawere K; Martini A; Treacy PJ; Voutsinas N; Knauer CJ; Sfakianos JP; Lewis SC; Taouli BA; Rastinehad AR BJU Int; 2020 Apr; 125(4):531-540. PubMed ID: 31762182 [TBL] [Abstract][Full Text] [Related]
26. Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer. Stabile A; Dell'Oglio P; Gandaglia G; Fossati N; Brembilla G; Cristel G; Dehò F; Scattoni V; Maga T; Losa A; Gaboardi F; Cardone G; Esposito A; De Cobelli F; Del Maschio A; Montorsi F; Briganti A Eur Urol Oncol; 2018 Jun; 1(2):120-128. PubMed ID: 31100235 [TBL] [Abstract][Full Text] [Related]
27. In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy? Salami SS; Ben-Levi E; Yaskiv O; Ryniker L; Turkbey B; Kavoussi LR; Villani R; Rastinehad AR BJU Int; 2015 Apr; 115(4):562-70. PubMed ID: 25252133 [TBL] [Abstract][Full Text] [Related]
28. Multiparametric MRI in detection and staging of prostate cancer. Boesen L Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066 [TBL] [Abstract][Full Text] [Related]
29. A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy. Baco E; Rud E; Eri LM; Moen G; Vlatkovic L; Svindland A; Eggesbø HB; Ukimura O Eur Urol; 2016 Jan; 69(1):149-56. PubMed ID: 25862143 [TBL] [Abstract][Full Text] [Related]
30. [Multiparametric MRI and MRI-TRUS fusion biopsy in patients with prior negative prostate biopsy]. Kesch C; Radtke JP; Distler F; Boxler S; Klein T; Hüttenbrink C; Hees K; Roth W; Roethke M; Schlemmer HP; Hohenfellner M; Hadaschik BA Urologe A; 2016 Aug; 55(8):1071-7. PubMed ID: 27168038 [TBL] [Abstract][Full Text] [Related]
31. An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-Preliminary experience. Costa DN; Kay FU; Pedrosa I; Kolski L; Lotan Y; Roehrborn CG; Hornberger B; Xi Y; Francis F; Rofsky NM Urol Oncol; 2017 Apr; 35(4):149.e15-149.e21. PubMed ID: 27939349 [TBL] [Abstract][Full Text] [Related]
32. Transperineal Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy Combined with Standard Template Improves Prostate Cancer Detection. Kim MM; Wu S; Lin SX; Crotty RK; Harisinghani M; Feldman AS; Wu CL; Dahl DM J Urol; 2022 Jan; 207(1):86-94. PubMed ID: 34428921 [TBL] [Abstract][Full Text] [Related]
33. Defining the learning curve for multiparametric magnetic resonance imaging (MRI) of the prostate using MRI-transrectal ultrasonography (TRUS) fusion-guided transperineal prostate biopsies as a validation tool. Gaziev G; Wadhwa K; Barrett T; Koo BC; Gallagher FA; Serrao E; Frey J; Seidenader J; Carmona L; Warren A; Gnanapragasam V; Doble A; Kastner C BJU Int; 2016 Jan; 117(1):80-6. PubMed ID: 25099182 [TBL] [Abstract][Full Text] [Related]
34. [Real-time MRI/US fusion-guided biopsy improves detection rates of prostate cancer in pre-biopsied patients]. Maxeiner A; Fischer T; Stephan C; Cash H; Slowinski T; Kilic E; Durmus T Aktuelle Urol; 2014 May; 45(3):197-203. PubMed ID: 24902069 [TBL] [Abstract][Full Text] [Related]
35. The diagnostic accuracy of multiparametric magnetic resonance imaging before biopsy in the detection of prostate cancer. Otti VC; Miller C; Powell RJ; Thomas RM; McGrath JS BJU Int; 2019 Jan; 123(1):82-90. PubMed ID: 29804315 [TBL] [Abstract][Full Text] [Related]
36. Infection rate and complications after 621 transperineal MRI-TRUS fusion biopsies in local anesthesia without standard antibiotic prophylaxis. Günzel K; Magheli A; Baco E; Cash H; Heinrich S; Neubert H; Schlegel J; Schostak M; Henkel T; Asbach P; Hinz S World J Urol; 2021 Oct; 39(10):3861-3866. PubMed ID: 33866401 [TBL] [Abstract][Full Text] [Related]
37. Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure. Cash H; Günzel K; Maxeiner A; Stephan C; Fischer T; Durmus T; Miller K; Asbach P; Haas M; Kempkensteffen C BJU Int; 2016 Jul; 118(1):35-43. PubMed ID: 26384851 [TBL] [Abstract][Full Text] [Related]
38. Incremental diagnostic value of targeted biopsy using mpMRI-TRUS fusion versus 14-fragments prostatic biopsy: a prospective controlled study. Mariotti GC; Falsarella PM; Garcia RG; Queiroz MRG; Lemos GC; Baroni RH Eur Radiol; 2018 Jan; 28(1):11-16. PubMed ID: 28687911 [TBL] [Abstract][Full Text] [Related]
39. A non-randomized prospective study on the diagnostic performance of perineal prostatic biopsy, directed via diffusion nuclear resonance, in patients with suspected prostate cancer and previous negative transrectal prostate biopsy. Castellucci R; Linares Quevedo AI; Sánchez Gómez FJ; Cogollos Acuña I; Salmerón Béliz I; Muñoz Fernández de Legaría M; Salinas S; Martínez Piñeiro L Urologia; 2021 Feb; 88(1):69-76. PubMed ID: 33054607 [TBL] [Abstract][Full Text] [Related]
40. Multicenter transperineal MRI-TRUS fusion guided outpatient clinic prostate biopsies under local anesthesia. Jacewicz M; Günzel K; Rud E; Lauritzen PM; Galtung KF; Hinz S; Magheli A; Baco E Urol Oncol; 2021 Jul; 39(7):432.e1-432.e7. PubMed ID: 33257219 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]